Applying science to care.

Medavera identifies gaps in knowledge and care, methodically researches the subject matter, identifies the top experts to guide the content, and then utilizes a format that will provide the best learning opportunity. We are always looking for new teaching methods and technologies in order to offer stimulating and actionable medical education. Medical education must be meaningful to become applied to clinical practice. Great content, respected leaders, and interesting formats create successful interactions and learning.
A CASE STUDY NOW IN DEVELOPMENT
COMING SOON TO A TOWN NEAR YOU
FEATURED PROJECT

New Paradigms in Heart Failure: RAAS Inhibition and the Management of Hyperkalemia

ESC Congress 2015 – London, United Kingdom
Saturday, August 29, 2015

During this live educational program moderated by Professor John McMurray, new options for the treatment of hyperkalemia in heart failure patients will be presented. Dr. Faiez Zannad, a world leader on this topic, will lead the discussion with current challenges in optimizing renin-angiotensin-aldosterone inhibitors (RAASi) and Dr. Ileana Piña will provide pragmatic advice on new pharmacological treatment options for RAASi. This exciting program will offer attendees new ideas for consideration to achieve better outcomes.

Keep up with medical meetings
Download the free app here.
MMD
THE MEDICAL NEWS
(Reuters) - The U.S. Food and Drug Administration approved Tesaro Inc's treatment for chemotherapy-induced nausea and vomiting in adults, the company said on Wednesday.... ZURICH (Reuters) - Switzerland on Wednesday closed a legal loophole that allowed cable car drivers to escape criminal prosecution if caught drunk on the job as the law did not impose an alcohol limit on them.... SACRAMENTO, Calif. (Reuters) - The number of inmates being observed for possible infection with Legionnaires' disease at San Quentin State Prison near San Francisco has jumped from 71 to 85, but the number of confirmed diagnoses held steady at six, authorities said Tuesday.... SACRAMENTO, Calif. (Reuters) - A controversial bill to allow physician-assisted suicide for terminally ill patients in California passed a key legislative committee on Tuesday, after failing in the legislature earlier this summer amid opposition from the Catholic Church.... LONDON (Reuters) - Medical researchers called on Wednesday for detailed, thoughtful debate on future use of new genetic technology that has the potential to create "designer babies".... (Reuters) - Amgen Inc said its experimental bone drug was found to be more effective than an already marketed drug in a late-stage study.... (Reuters Health) - Advances in genetic testing may eventually allow for more tailored care for people with an autism spectrum disorder (ASD), researchers say.... (Reuters Health) - More minority patients have been getting kidney transplants since 2003, when medical criteria for allocating transplantable kidneys from deceased donors were loosened, according to a new study.... LONDON (Reuters) - Novartis and Amgen are joining forces in the hunt for an Alzheimer's treatment, in the latest sign that drugmakers believe an effective therapy for the memory-robbing disease may be within reach.... NEW YORK (Reuters) - Ten weeks after closing its $8.4 billion purchase of Synageva BioPharma Corp, Alexion Pharmaceuticals Inc on Tuesday announced European approval for the key drug acquired through the deal, an enzyme-replacement therapy for an ultra-rare, life threatening disease.... Boston, Massachusetts - In a laboratory at Boston Children's Hospital a cure for genetic deafness is taking shape. Lead researcher Jeff Holt says that if all goes as planned, children of the future who lose their ability to hear due to genetic mutation will never go deaf.... (Reuters) - The Food and Drug Administration on Tuesday issued warning letters to five distributors of pure powdered caffeine, as the federal agency stepped up efforts to curtail ingestion of the stimulant in its pure form.... (Reuters) - Seven people have died and 32 sickened in a Legionnaires' disease outbreak at a veterans home in Quincy, Illinois, state veterans and health officials said in a statement on Tuesday.... CHICAGO (Reuters) - Three out of four U.S. adults have a predicted "heart age" that is older than they are, putting them at increased risk for heart attacks and strokes, government researchers said on Tuesday.... (Reuters) - Europe's pharmaceuticals industry said on Tuesday it had filed a complaint with the European Commission against a French law promoting the use of Roche's cancer drug Avastin as a cheap eye treatment.... (Reuters Health) - Wrist-worn activity trackers, increasingly popular among consumers and in healthcare research, can vary considerably in their accuracy, a study from Iowa State University suggests.... (Reuters Health) - Between 1998 and 2013, adult bicycling injuries rose sharply in the U.S., largely among riders over age 45, a new study shows.... PARIS (Reuters) - Sanofi and Regeneron Pharmaceuticals said on Tuesday that a study into their new cholesterol-lowering drug, Praluent, showed promising results.... LONDON (Reuters) - Amgen is launching its injectable cholesterol drug in Europe at around half the U.S. price, in a move likely to stoke controversy about the way Americans end up paying far more than others for new medicines.... BEIJING (Reuters) - China enforced sweeping new rules on Tuesday to restrict tobacco advertisements, in its latest step to rein in a widespread habit that has caused a massive health crisis....